Newsroom / Press Releases
Contact: media.relations@hra-pharma.com
| April 25, 2013 Paris, France |
| December 3, 2012 Paris, France |
HRA Pharma’s CEO, Erin Gainer, honored with La Tribune Women's Award |
| November 23, 2012 Paris, France |
HRA Pharma announce adrenocortical carcinoma award winners at ENS@T 2012 |
| September 4, 2012 Paris, France |
|
| February 27, 2012 Paris, France |
|
| February 2, 2012 Paris, France |
| December 16, 2011 Paris, France |
HRA Pharma’s partner, Preglem, the wholly owned subsidiary of Gedeon Richter Plc., receives positive CHMP opinion for uterine fibroids treatment. |
| December 5, 2011 Paris, France & Budapest, Hungary |
HRA Pharma grants Richter marketing rights for Esmya for China, Russia and other CIS republics |
| November 17, 2011 Paris, France |
Riverside provides growth capital to France's HRA Pharma |
| October 10, 2011 Paris, France |
HRA Pharma wins the 2011 Prix de l'Ambition |
| September 20, 2011 Paris, France and Singapore |
ella® approved in Singapore |
| September 20, 2011 Seoul, South Korea and Paris, France |
First Launch of ellaOne® in Asia |
| May 24, 2011 Tokyo, Japan and Paris, France |
HRA Pharma welcomes the launch of NorLevo® as the first Emergency Contraceptive Pill to become available in Japan |
| May 20, 2011 Tokyo, Japan and Paris, France |
ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for ulipristal acetate to treat uterine fibroids in Japan |
| May 19th, 2011 Tokyo, Japan and Paris, France |
ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for ellaOne® in Japan |
| February 23, 2011 Paris, France |
NorLevo® the First Emergency Contraceptive to Receive Marketing Approval in Japan. |
| February 16, 2010 Paris, France |
HRA Pharma's NorLevo® Now the First Emergency Contraceptive Available Without a Prescription in Ireland. |
| December 20, 2010 Paris, France |
HRA Pharma Enters into Agreement with Chemo to Commercialize Novel Emergency Contraceptive in Central and South America. |
| December 2, 2010 Paris, France Seoul, South Korea |
Shin Poong Pharma and HRA Pharma Announce Exclusive Licensing Agreement for Ulipristal Acetate in South Korea. |
| December 1, 2010 Paris, France |
HRA Pharma’s Emergency Contraceptive ella® Now Available in the U.S. |
| September 20, 2010 Paris, France |
ellaOne® now reimbursed in France. |
| September 17, 2010 Paris, France & Morristown, NJ, U.S. |
HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada. |
| September 17, 2010 Paris, France |
Erin Gainer, CEO of HRA Pharma, Recognized for Her Leadership Role in the Pharmaceutical Industry. |
| August 13, 2010 Paris, France |
FDA grants approval of ella® for emergency contraception. |
| July 15, 2010 Paris, France |
Ulipristal acetate (ellaOne®) significantly reduces pregnancy risk versus levonorgestrel for oral emergency contraception. |
| June 17, 2010 Paris, France |
FDA Advisory Committee Unanimously Recommends Approval of HRA Pharma's Ulipristal Acetate for Emergency Contraception. |
| May 21, 2010 Paris, France |
HRA Pharma's Partner Preglem Announces Positive Phase III Results for Ulipristal Acetate in the Treatment of Uterine Fibroids. |
| April 27, 2010 Paris, France |
HRA Pharma Announces FDA Advisory Committee Review of Ulipristal Acetate. |
| April 12, 2010 Paris, France & Geneva, Switzerland |
Preglem licenses additional rights for ulipristal acetate from HRA Pharma. |
| February 11, 2010 Paris, France |
HRA Pharma's new emergency contraceptive ellaOne® accepted by the Scottish Medicines Consortium. |
| February 01, 2010 Paris, France & Morristown, N.J., United States |
Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S. |
| January 29, 2010 Paris, France |
Breaking News in Emergency Contraception: HRA Pharma Unveils Clinical Data on ellaOne®. |
| December 18, 2009 Paris, France & Madrid, Spain |
HRA Pharma Expands to Spain and Launches ellaOne®. |
| November 9, 2009 Paris, France |
HRA Pharma's NorLevo® on its way to becoming the first emergency contraceptive pill available in Japan. |
| November 9, 2009 Paris, France & Taipei, Taiwan |
HRA Pharma's emergency contraceptive ella® in motion in Asia |
| October 6, 2009 Paris, France & Singapore |
HRA Pharma Marks First Step for ella® in Asia. |
| October 1, 2009 Paris, France |
HRA Pharma Launches ellaOne® in Europe. |
| September 23, 2009 Paris, France |
HRA Pharma Announces European Marketing and Distribution Agreement with Acrux. |
| September 18, 2009 Paris, France |
HRA Pharma Named Finalist for the 2009 Scrip Awards and the 2009 Clinical Research Excellence Awards. |
| September 17, 2009 Paris, France & Roma, Italy |
HRA Pharma Reinforces Operational Presence in Europe with Italian Subsidiary. |
| June 10, 2009 Paris, France |
NorLevo®, HRA Pharma's Emergency Contraceptive Pill, Now Available in Canada. |
| July 1, 2009 Paris, France & London, UK |
HRA Pharma Marks Next Step in European Expansion with UK Subsidiary. |
| May 26, 2009 Paris, France |
HRA Pharma Granted European Marketing Authorization for ellaOne®. |
| May 11, 2009 Paris, France & Geneva, Switzerland |
HRA PHARMA AND PREGLEM ANNOUNCE SUCCESSFUL COMPLETION OF PHASE IIB FOR ULIPRISTAL ACETATE FOR THE TREATMENT OF UTERINE FIBROIDS. |
| April 28, 2009 Paris, France |
HRA Pharma Appoints Erin Gainer as CEO to Lead Company Through Next Phases of International Growth. |
| April 7, 2009 Paris, France |
HRA Pharma and Nycomed Reinforce Partnership with Marketing and Distribution Agreement for ellaOne® |
| March 20, 2009 Paris, France |
HRA Pharma Receives CHMP Positive Opinion for ellaOne® |
| February 17, 2009 Paris, France and Budapest, Hungary |
HRA Pharma and Gedeon Richter Enter into Marketing and Distribution Agreement |
| December 2, 2008 Paris, France and Bochum, Germany |
HRA Pharma Strengthens European Operations with German Affiliate. |
| December 4, 2007 Paris, France |
HRA Pharma enters licensing agreement with PregLem to develop and commercialise ulipristal for gynecological disorders. |
| November 27, 2007 Bamako, Mali |
Being aware that humanitarian programs should not be restricted to the company's area of business, and because cultural development is a necessity for development, HRA has sponsored an award at the "Rencontres africaines de la photographie" aimed to reward the work of a young African photographer who displays unique talent and a potential for excellence. |
| November 27, 2007 Bamako, Mali |
HRA Pharma is sponsoring the "Afrique en créations" prize aimed to reward the work of a young, talented African photographer. |
| March 26, 2007 Paris, France |
HRA Pharma commences UK-based Phase III trial of Ella®, a second-generation emergency contraceptive |
| February 28, 2007 Paris, France |
HRA Pharma invest an additional € 2.5 M in cell therapy through its subsidiary Celogos |
| February 15, 2007 Paris, France |
Stem Cell Sciences and Celogos sign a licensing deal on autogenous myoblast transplantation |
| December 7, 2006 Paris, France |
HRA Pharma commences US Phase III trial of new emergency contraceptive |